- News & Features
"By telling our personal stories about living with arthritis, we can help ensure that elected officials make wise decisions about legislation that makes medications and treatments accessible"
Biosimilars carry about a 20 to 30 percent reduction in cost over the biologics that they resemble, says Dr. Candida Fratazzi.
Amjevita, a biosimilar to Humira (adalimumab), was approved by the FDA for treatment of a number of inflammatory diseases.
On January 7, 2005, Lene Andersen got her first injection of a biologic—she went home, took a nap, and woke up a different person.
Highlights of the Joint Decisions webinar on the types of insurance that people with RA have and how to make sure you get the coverage you need
Two leaders in the field of rheumatology discussed the most influential studies that have been done and issues that have come to the forefront this year: Apremilast, a new drug approved for psoriatic arthritis, the rise of biosimilar drugs, and a new way of thinking about immune dysfunction.
Can you or your hairdresser tell the state of your health by the way your hair behaves?
Ms. Meniscus advises a woman seriously considering having an affair.
Brenda has learned from living with Rheumatoid Arthritis for the past 21 years, that battles and blessings do go hand in hand with coping.
Lana explains what role genes have in developing Rheumatoid Arthritis (RA).